Trustsubmit

Life-sciences teams using AI models in regulatory work can struggle to assemble context of use, model description, data provenance, validation methodology, performance evidence and limitations into one coherent record. The supplied research confirms a final federal credibility-assessment framework and says its report may accompany a submission or be provided on request. It also confirms open experiment-tracking and signing substrates while finding no reviewed specialist dossier generator.

Trustsubmit would preserve intended context of use, model and artifact versions, training and evaluation dataset assertions, lineage sources, validation plan, acceptance criteria, experiment run, metric definition, observed result, limitation, deviation, corrective action, literature citation, citation-resolution result, reviewer comment, approval, export and agency response. A structured intake could surface missing evidence but would not fill it.

Experiment logs show recorded events, not necessarily complete or validated evidence. A signature supports bounded artifact integrity, not model quality, data rights or truth. Citation metadata can confirm that a publication exists; it cannot establish that the cited claim is relevant, reproduced or scientifically sound. Generated prose can hide contradictions across sections. Regulatory affairs, quality, statistics, clinical, scientific and legal owners retain interpretation and approval.

Model artifacts, datasets and submission plans can contain trade secrets, patient-derived information and confidential regulatory strategy. The pilot should use synthetic or public fixtures, read-only imports and no production submission. Access, retention, export and deletion require validation. The buyer hypothesis is a regulatory affairs, quality, model-risk or ML leader at a life-sciences company preparing AI credibility evidence; product type, submission stage, model role, budget, source systems and existing consultants need validation.

A regulatory affairs, quality, model-risk or ML leader assembling AI credibility evidence for a life-sciences regulatory workflow.